The 4th International Medical Cannabis Conference, titled CannX, will take place in Tel Aviv this September. The conference will welcome health and agriculture professionals, investors, startups, scientists, clinicians, researchers, and entrepreneurs from all over the world to to gain access to new developments, innovations, and opportunities in the emerging medical cannab
The conference will include three tracks devoted to science, business, and agriculture as well as lectures by leading international and Israeli speakers. There will be keynotes by Raphael Mechoulam, the Israeli man credited with laying the foundation for the scientific research of cannabis as well as Jonathan Page, chief science officer for Canadian company Aurora Cannabis. Other speakers include Philippe Lucas, vice president of patient research and access for Canadian pharmaceutical and cannabis company Tilray, and Kevin Roland, Director of CMC Canopy Health Innovation and Canopy Growth Corporation as well as sessions with cancer researcher Professor Dedi Meiri, Professor David Casarett, and Lumír Ondřej Hanuš.
Get our weekly newsletter directly in your inbox!Sign up
The conference will include a dedicated startup pavilion where companies will be able to exhibit their products and services.
CannX is held in partnership with Cann10, the trusted global partner for medical cannabis investment, start-ups, R&D, growth, trade know-how and education
CannX is a leading international conference series on medical cannabis, with conferences coming up in Tel Aviv, Lisbon, Portugal and Sao Paolo, Brazil.
CannX in Tel Aviv will run September 9 – 10.